Scholars Central

Short communicationPublished 29 Feb 2024

Innovations in Diabetes Management: Clinical Drug Trials and Beyond

Authors: Osama Mohammed

Department of Materials, Sichuan University, PR China

Clinical Pharmacology & Biopharmaceutics

Volume 13 · Issue 2 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Diabetes mellitus represents a significant global health challenge, with its prevalence escalating rapidly across all regions of the world. As the burden of diabetes continues to grow, there is an urgent need for innovative approaches to its management. Clinical drug trials play a pivotal role in driving advancements in diabetes care, but beyond pharmacotherapy, a diverse array of innovations is reshaping the landscape of diabetes management. This abstract provides an overview of the latest innovations in diabetes management, encompassing both clinical drug trials and broader strategies aimed at improving patient outcomes and quality of life. Clinical drug trials constitute a cornerstone in the development of new pharmacotherapies for diabetes. Recent years have witnessed a surge in the development of novel drug classes, including sodium-glucose cotransporter-2 (SGLT-2) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and dual SGLT-1/SGLT-2 inhibitors. These agents offer unique mechanisms of action and demonstrate efficacy in improving glycemic control, reducing cardiovascular risk, and promoting weight loss, thereby expanding the treatment armamentarium for patients with diabetes. Furthermore, advancements in diabetes technology have revolutionized the way patients monitor and manage their condition. Continuous glucose monitoring (CGM) systems provide real-time glucose data, enabling individuals with diabetes to make informed decisions regarding insulin dosing, dietary choices, and physical activity. The integration of CGM with insulin pumps in closed-loop systems, or

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Osama Mohammed”